Bridle Path Investments is an investment banking and venture capital advisory firm focused on healthcare, biotechnology, pharmaceuticals, diagnostics, medical devices, and related innovation.

 

Founded by biotechnology executive and investor Ruvin Orbach, the firm works with companies, investors, family offices, venture capital firms, and strategic partners in the U.S. and internationally. Bridle Path provides personalized guidance in business development, financing strategy, investor relationships, and cross-border opportunities.